Display options
Share it on

Dermatol Ther (Heidelb). 2014 Jun;4(1):125-9. doi: 10.1007/s13555-014-0045-2. Epub 2014 Feb 22.

Melanoma of non-sun exposed skin in a man with previous prostate cancer: recognition of a recently confirmed association.

Dermatology and therapy

Philip R Cohen

Affiliations

  1. Division of Dermatology, University of California, San Diego, CA, USA, [email protected].

PMID: 24563423 PMCID: PMC4065282 DOI: 10.1007/s13555-014-0045-2

Abstract

BACKGROUND: The association of an increased risk to develop melanoma in patients with prostate cancer has recently been confirmed.

PURPOSE: The postulated etiologic relationship between prostate cancer and the subsequent occurrence of melanoma is discussed.

METHODS: A man with previous prostate cancer who developed melanoma on the plantar surface of his left great toe is described and the possibility of high levels of endogenous androgens promoting not only prostate cancer, but also increased risk of melanoma are reviewed.

RESULTS: Modification of the host immune response, alteration of chromosome telomere length, and/or imbalance of androgen level (presenting as severe teenage acne) are potential mechanisms whereby high levels of endogenous androgens may contribute to the association between prostate cancer and risk of melanoma.

CONCLUSIONS: An increased surveillance for melanoma should be considered in prostate cancer patients. Complete skin examination in men who have had prostate cancer-especially in those individuals diagnosed with prostate cancer prior to age 68 years-should regularly be performed.

References

  1. Physiol Rev. 2004 Oct;84(4):1155-228 - PubMed
  2. Br J Cancer. 1980 Apr;41(4):652-6 - PubMed
  3. Aging (Albany NY). 2013 Jan;5(1):3-17 - PubMed
  4. Int J Cancer. 2007 Dec 15;121(12):2688-92 - PubMed
  5. J Clin Oncol. 2013 Dec 10;31(35):4394-9 - PubMed
  6. Nat Rev Cancer. 2012 Mar 01;12(4):289-97 - PubMed
  7. Eur J Cancer Prev. 2012 Nov;21(6):552-9 - PubMed
  8. J Natl Cancer Inst Monogr. 2000;(27):39-66 - PubMed
  9. Facial Plast Surg Clin North Am. 2013 Feb;21(1):33-42 - PubMed
  10. Arch Dermatol. 2011 Dec;147(12):1395-402 - PubMed
  11. Ann N Y Acad Sci. 2006 Nov;1089:168-76 - PubMed
  12. Melanoma Res. 2002 Dec;12(6):529-38 - PubMed
  13. J Biol Chem. 2010 Apr 2;285(14):10472-6 - PubMed
  14. Blood. 2009 Sep 10;114(11):2236-43 - PubMed
  15. Nat Rev Clin Oncol. 2014 Jan;11(1):24-37 - PubMed
  16. J Surg Res. 2003 Apr;110(2):393-8 - PubMed
  17. Cancer Res. 2011 Nov 1;71(21):6758-63 - PubMed
  18. Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1319-29 - PubMed
  19. Immunotherapy. 2013 Feb;5(2):169-82 - PubMed
  20. J Clin Oncol. 2011 Sep 20;29(27):3677-85 - PubMed
  21. Lancet. 1980 Mar 15;1(8168 Pt 1):562-4 - PubMed
  22. N Engl J Med. 1989 Jul 20;321(3):129-35 - PubMed
  23. J Natl Cancer Inst. 1993 Oct 6;85(19):1571-9 - PubMed
  24. Lancet. 2012 Jan 28;379(9813):361-72 - PubMed
  25. J Carcinog. 2011;10:33 - PubMed
  26. CA Cancer J Clin. 2013 Jan;63(1):11-30 - PubMed
  27. J Natl Cancer Inst. 1996 Aug 21;88(16):1118-26 - PubMed

Publication Types